About CTRP

NCI's Clinical Trials Reporting Program (CTRP) was established in response to a recommendation made by the NCI Clinical Trials Working Group (CTWG) to the National Cancer Advisory Board, and reiterated by the Institute of Medicine’s report titled A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program.

CTRP is designed to be a comprehensive database of regularly updated information, including accrual, on all NCI-supported clinical trials. This comprehensive database of the entire NCI portfolio will help identify gaps in clinical research and duplicative studies, as well as facilitate effective clinical trial prioritization and enhance patient accrual to trials by making physicians aware of relevant opportunities for participation in clinical trials.

The AACI-NCI Clinical Trials Reporting Program (CTRP) Strategic Subcommittee Report: CTRP Reporting Objectives and Implementation Timeline, July 2011 (PDF:1 MB) provides additional information regarding CTRP.